EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients

Hidenao Noritake iD, Yoshimasa Kobayashi iD, Yukimasa Ooba, Kensuke Kitsugi, Shin Shimoyama, Satoru Yamazaki, Takeshi Chida iD, Shinya Watanabe, Kazuhito Kawata, Takafumi Suda

ISRN Hepatology · 2014

DOI: 10.1155/2014/875140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Hepatology, 2014. Verfasst von Hidenao Noritake und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatology, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 4…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims . To examine the changes in serum alpha-fetoprotein (AFP) levels after iron reduction by therapeutic phlebotomy in chronic hepatitis C patients.

Methods

This retrospective study included 26 chronic hepatitis C patients. The patients were developed iron depletion by repeated therapeutic phlebotomies.

Results

Iron reduction therapy significantly reduced the median level of serum AFP from 13 to 7 ng/mL, ALT from 96 to 50 IU/L, gamma-glutamyl transpeptidase (GGT) from 55 to 28 IU/L, and ferritin from 191 to 10 ng/mL ( P < 0.001 for each). The rate of decline in the AFP level correlated positively only with that in GGT ( r = 0.695 , P = 0.001 ) , although a spurious correlation was observed between the rates of decline for AFP and ALT. The AFP level normalized (

Autor:innen und Institutionen

  • Division of Hepatology, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan.
  • Division of Respiratology, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka 431-3192, Japan.

ORCID-Profile: Hidenao Noritake, Yoshimasa Kobayashi, Takeshi Chida

Zitieren

APA

Noritake, H., Kobayashi, Y., Ooba, Y., Kitsugi, K., Shimoyama, S., Yamazaki, S., Chida, T., Watanabe, S., Kawata, K., & Suda, T. (2014). Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients. ISRN Hepatology. https://doi.org/10.1155/2014/875140

Vancouver

Noritake H, Kobayashi Y, Ooba Y, Kitsugi K, Shimoyama S, Yamazaki S, et al. Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients. ISRN Hepatology. 2014. doi:10.1155/2014/875140

BibTeX
@article{Noritake2014,
  author = {Noritake, Hidenao and Kobayashi, Yoshimasa and Ooba, Yukimasa and Kitsugi, Kensuke and Shimoyama, Shin and Yamazaki, Satoru and Chida, Takeshi and Watanabe, Shinya and Kawata, Kazuhito and Suda, Takafumi},
  title = {Improved Serum Alpha-Fetoprotein Levels after Iron Reduction Therapy in HCV Patients},
  journal = {ISRN Hepatology},
  year = {2014},
  doi = {10.1155/2014/875140}
}
Kostenlos starten →